
Reportlinker Adds HIV Diagnostics Market in India
NEW YORK, June 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
HIV diagnostics market in India
This report covers the HIV diagnostics market in India. HIV stands out as a highly lucrative and expanding market for diagnostics because of the close integration of diagnostics in day-to-day disease diagnosis, management, and drug selection. HIV was first identified in India in 1986, in Chennai, shortly after the Indian Council of Medical Research (ICMR) initiated surveillance for HIV. Surveillance was later taken over by the National AIDS Control Organization (NACO), set up under the Ministry of Health and Family Welfare.
India is planning to scale up prevention of HIV to avoid having to spend an increasing share of its health budget on treatment of AIDS patients, according the World Bank and other agencies. India has over 2.5 million AIDS patients currently. India spends about 5 percent of its $5.4 billion healthcare budget on treating AIDS patients. India may have to spend $1.8 billion by 2020, about 7 percent of the total health expenditure, the World Bank said.
Executive Summary
Industry Overview (Global & Indian)
Biomedical research on HIV/AIDS in India
e) Tamil Nadu
f) Manipur
g) Mizoram
h) Nagaland
i) The Punjab
Market Structure and Segmentation
Types of Products
Key Players
Competition situation
Key Drivers
Key Challenges / Barriers
Supply system – supply situation
Key Opportunities
Key Success factors
Regulatory Advantage & legal frameworks
Diagnostics Technologies for India
Industry SWOT
Annexure
List of charts & tables
Industry associations
Certifying authorities
Bibliography
To order this report:
Pathology Industry: HIV diagnostics market in India
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article